-
-
-
-
-
-
-
Radoff-JEC Group seeks board changes at Seer amid 97% share decline
-
-
-
-
-
-
-
Seer to Showcase AI-Driven Multi-Cancer Screening Approach and Next-Generation Proteomics Capabilities at ASMS 2026
-
-
-
-
-
-
-
The Radoff-JEC Group Responds to Seer, Inc.’s Rejection of April 24th Acquisition Proposal
-
-
-
-
-
-
-
Radoff-JEC Group offers to acquire Seer for $2.25 per share
-
-
-
-
-
-
-
Seer Enters into a Co-Marketing and Sales Agreement with Thermo Fisher Scientific
-
-
-
-
-
-
-
Senti Bio and Dynamics Special Purpose Corp. Announce Business Combination Agreement to Create Publicly Listed Company Pioneering Gene Circuit-Engineered Cell and Gene Therapies
-
-
1,164,381 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

